- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Wave Life Sciences Ltd (WVE)
Wave Life Sciences Ltd stock price live, this page displays NASDAQ WVE stock exchange data. View the WVE premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Wave Life Sciences Ltd real time stock price chart below.
What Is the Wave Life Sciences Ltd Stock Price Today?
The Wave Life Sciences Ltd stock price today is 5.410.
What Is the Stock Symbol for Wave Life Sciences Ltd?
The stock symbol for Wave Life Sciences Ltd is "WVE."
What Stock Exchange Does Wave Life Sciences Ltd Trade On?
Wave Life Sciences Ltd is listed and trades on the NASDAQ stock exchange.
Is Wave Life Sciences Ltd a Good Stock to Buy?
Determining whether Wave Life Sciences Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the WVE quote. (ISIN: US94352A1043)
What Is the Wave Life Sciences Ltd Stock Price Today?
The Wave Life Sciences Ltd stock price today is 5.410.
What Is the Stock Symbol for Wave Life Sciences Ltd?
The stock symbol for Wave Life Sciences Ltd is "WVE."
What Stock Exchange Does Wave Life Sciences Ltd Trade On?
Wave Life Sciences Ltd is listed and trades on the NASDAQ stock exchange.
Is Wave Life Sciences Ltd a Good Stock to Buy?
Determining whether Wave Life Sciences Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the WVE quote. (ISIN: US94352A1043)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.140
5.420
52 wk Range
5.010
21.730
WVE is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.1405.420
52 wk Range
5.01021.730
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
WVE Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
19.063
Upside
+252.36%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Wave Life Sciences stock hits 52-week low at $5.01- Investing.com
Form 8K Wave Life Sciences For: 7 August- Investing.com
- Wave Life Sciences stock hits 52-week low at $5.01
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral
Analyst Ratings
16 Buy
0 Hold
0 Sell
Ratings:
16 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 19.063
(+252.36% Upside)
Wave Life Sciences Ltd SWOT Analysis
RNA Editing Pionee | Wave Life Sciences leads in RNA editing oligonucleotides, targeting genetic diseases with a diverse pipeline and promising early-stage results in key programs |
AATD Breakthrough | Explore WVE-006's potential for monthly dosing in alpha-1 antitrypsin deficiency, with favorable regulatory pathways and encouraging safety data |
Obesity Market Entry | Delve into Wave's unique INHBE-targeting approach for obesity treatment, offering potential yearly dosing and differentiation in a competitive landscape |
Financial Outlook | Analyst price targets range from $9 to $36, with a consensus "Strong Buy" recommendation despite near-term profitability challenges |
Wave Life Sciences Ltd Earnings Call Summary for Q2/2026
- Wave Life Sciences posted Q2 2026 loss of $0.34/share vs. $0.30 estimate; revenue fell 73.6% to $2.3M, missing $7.65M forecast by 70%.
- R&D spending rose 18% to $51.3M and G&A jumped 37.8% to $24.8M as company advanced WVE-007, WVE-006, and WVE-008 pipeline programs.
- Company holds $490.6M in cash, sufficient to fund operations through Q3 2028; expects GSK milestone payments in H2 2026.
- FDA granted meeting for late summer to discuss potential accelerated approval pathway for WVE-006 in AATD; WVE-007 Phase IIa enrollment ongoing.
- Shares fell 2.75% to $5.65, near 52-week low of $5.02; stock down 66% YTD despite analyst price targets ranging from $12 to $43.
Last Updated: 2026-07-30, 10:00 a/m
Read Full TranscriptEarnings
Latest Release
Jul 30, 2026
EPS / Forecast
-0.34 / -0.30
Revenue / Forecast
2.3M / 7.65M
Compare WVE to Peers and Sector
Metrics to compare | WVE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipWVEPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.3x | −6.4x | −0.4x | |
PEG Ratio | 0.18 | 0.40 | 0.00 | |
Price/Book | 2.4x | 1.9x | 2.6x | |
Price / LTM Sales | 16.3x | 11.3x | 3.1x | |
Upside (Analyst Target) | 177.0% | 50.3% | 47.8% | |
Fair Value Upside | Unlock | −0.2% | 6.2% | Unlock |
Wave Life Sciences, Inc., a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health. Its RNA medicines platform, PRISM, combines RNA medicine modalities, chemistry innovation, and deep insights in human genetics to deliver scientific breakthroughs that treat rare and common disorders. Its pipeline focuses on obesity (WVE-007), alpha-1 antitrypsin deficiency (AATD) (WVE-006), and PNPLA3 I148M liver disease (WVE-008) programs; and clinical programs for Duchenne muscular dystrophy and Huntington’s disease, as well as various preclinical programs utilizing its RNA medicines platform. Wave Life Sciences, Inc. was founded in 2012 and is headquartered in Cambridge, Massachusetts.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Wave Life Sciences Ltd (WVE) Stock Price Today?
The Wave Life Sciences Ltd stock price today is 5.410 USD.
What Stock Exchange Does Wave Life Sciences Ltd Trade On?
Wave Life Sciences Ltd is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Wave Life Sciences Ltd?
The stock symbol for Wave Life Sciences Ltd is "WVE."
What Is the Wave Life Sciences Ltd Market Cap?
As of today, Wave Life Sciences Ltd market cap is 1.020B USD.
What Is Wave Life Sciences Ltd's Earnings Per Share (TTM)?
The Wave Life Sciences Ltd EPS (TTM) is -1.077.
When Is the Next Wave Life Sciences Ltd Earnings Date?
Wave Life Sciences Ltd will release its next earnings report on Nov 05, 2026.
From a Technical Analysis Perspective, Is WVE a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Wave Life Sciences Ltd Stock Split?
Wave Life Sciences Ltd has split 0 times.
How Many Employees Does Wave Life Sciences Ltd Have?
Wave Life Sciences Ltd has 317 employees.
What is the current trading status of Wave Life Sciences Ltd (WVE)?
As of Aug 15, 2026, Wave Life Sciences Ltd (WVE) is trading at a price of 5.410 USD, with a previous close of 5.200 USD. The stock has fluctuated within a day range of 5.140 USD to 5.420 USD, while its 52-week range spans from 5.010 USD to 21.730 USD.
What Is Wave Life Sciences Ltd (WVE) Price Target According to Analysts?
The average 12-month price target for Wave Life Sciences Ltd is 19.063 USD, with a high estimate of 42 USD and a low estimate of 12 USD. 16 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +252.36% Upside potential.
What Is the WVE Premarket Price?
WVE's last pre-market stock price is 5.240 USD. The pre-market share volume is 3,810.000, and the stock has decreased by 0.040, or 0.770%.
What Is the WVE After Hours Price?
WVE's last after hours stock price is 5.400 USD, the stock has decreased by -0.010, or -0.180%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.